Hostname: page-component-669899f699-g7b4s Total loading time: 0 Render date: 2025-04-28T06:52:48.563Z Has data issue: false hasContentIssue false

Genistein inhibits Nlrp3/caspase-1 signalling to alleviate traumatic brain injury-induced anxiety-like behaviours in rats

Published online by Cambridge University Press:  27 September 2024

Zhiguang Li
Affiliation:
Department of Neurology, Xingtai Central Hospital, Xingtai, HE, China
Yan Li
Affiliation:
Department of Neurology, Xingtai Central Hospital, Xingtai, HE, China
Jiankai Zhao
Affiliation:
Department of Neurology, Xingtai Central Hospital, Xingtai, HE, China
Zhiyin Pang
Affiliation:
Department of Neurology, Xingtai Central Hospital, Xingtai, HE, China
Fei Guo*
Affiliation:
Department of Basic Medicine, Xingtai Medical College, Xingtai, HE, China
*
Corresponding author: F. Guo; Email: [email protected]

Abstract

Objective:

Traumatic brain injury (TBI)-induced anxiety is a common but under-investigated disorder, for which neuroinflammation is a significant contributor. Here we aim to investigate the protective effects of genistein, a plant-derived anti-inflammatory drug, against TBI-induced anxiety, and the underlying mechanisms.

Methods:

A rat model of TBI was constructed using the lateral fluid percussion injury method. Genistein at the doses of 5, 10, and 20 mg/kg were used to treat rats at 30 min, 12 h, 24 h, 48 h, and 72 h up to 14 days after TBI. The evaluation of neurological deficit was performed preoperatively, on days 1, 3, 7, and 14 after TBI. The elevated plus maze test was carried out to assess anxiety and explorative behaviours, and the open field test was performed to assess locomotive activities. Brain injury was assessed by measuring brain water content and TdT-mediated dUTP Nick-End Labeling staining. Inflammatory responses were examined using enzyme-linked immunosorbent assay. The mRNA and protein expression were analysed using real-time polymerase chain reaction and Western blot, respectively.

Results:

In the behavioural level, genistein treatment alleviated TBI-induced anxiety behaviours and neurological deficit in rats. In the meanwhile, brain oedema was also reduced by genistein treatment, showing alleviating effects of genistein at the pathological level. TUNEL staining also showed reduced apoptosis in rats treated with genistein. Genistein also inhibited Nlrp3/caspase-1 signalling, unveiling the effects of genistein in altering molecular pathways in brains with TBI.

Conclusion:

Genistein alleviates anxiety-like behaviours in TBI rats, which may be mediated via inhibiting Nlrp/caspase-1 signalling pathway.

Type
Original Article
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of Scandinavian College of Neuropsychopharmacology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Alder, J, Fujioka, W, Lifshitz, J, Crockett, DP and Thakker-Varia, S (2011) Lateral fluid percussion: model of traumatic brain injury in mice. J Vis Exp 22(54), 3063.Google Scholar
Alishahi, M, Farzaneh, M, Ghaedrahmati, F, Nejabatdoust, A, Sarkaki, A and Khoshnam, SE (2019) NLRP3 inflammasome in ischemic stroke: as possible therapeutic target. Int J Stroke 14(6), 574591.CrossRefGoogle ScholarPubMed
Aravind, A, Ravula, AR, Chandra, N and Pfister, BJ (2020) Behavioral deficits in animal models of blast traumatic brain injury. Front Neurol 11, 990.CrossRefGoogle ScholarPubMed
Brett, BL, Kramer, MD, Whyte, J, McCrea, MA, Stein, MB, Giacino, JT, Sherer, M, Markowitz, AJ, Manley, GT, Nelson, LD, Badjatia, N, Boase, K, Barber, J, Bodien, Y, Bullock, MR, Chesnut, R, Corrigan, JD, Crawford, K, Diaz-Arrastia, R,…and Zafonte, R (2021) Latent profile analysis of neuropsychiatric symptoms and cognitive function of adults 2 weeks after traumatic brain injury: findings from the TRACK-TBI study. JAMA Netw Open 4(3), e213467e67.CrossRefGoogle ScholarPubMed
Carron, SF, Sun, M, Shultz, SR and Rajan, R (2020) Inhibitory neuronal changes following a mixed diffuse-focal model of traumatic brain injury. J Comp Neurol 528(2), 175198.CrossRefGoogle ScholarPubMed
Duan, X, Li, Y, Xu, F and Ding, H (2021) Study on the neuroprotective effects of genistein on Alzheimer’s disease. Brain Behav 11(5), e02100.CrossRefGoogle Scholar
Fuloria, S, Yusri, MAA, Sekar, M, Gan, SH, Rani, NNIM, Lum, PT, Ravi, S, Subramaniyan, V, Azad, AK, Jeyabalan, S, Wu, YS, Meenakshi, DU, Sathasivam, KV and Fuloria, NK (2022) Genistein: a potential natural lead molecule for new drug design and development for treating memory impairment. Molecules 27(1), 265.CrossRefGoogle ScholarPubMed
Guo, B, Zhang, M, Hao, W, Wang, Y, Zhang, T and Liu, C (2023) Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression. Transl Psychiatry 13(1), 5.CrossRefGoogle ScholarPubMed
Kalra, S, Malik, R, Singh, G, Bhatia, S, Al-Harrasi, A, Mohan, S, Albratty, M, Albarrati, A and Tambuwala, MM (2022) Pathogenesis and management of traumatic brain injury (TBI): role of neuroinflammation and anti-inflammatory drugs. Inflammopharmacology 33(4), 11531166.CrossRefGoogle Scholar
Lazarevic, B, Boezelijn, G, Diep, LM, Kvernrod, K, Ogren, O, Ramberg, H, Moen, A, Wessel, N, Berg, RE, Egge-Jacobsen, W, Hammarstrom, C, Svindland, A, Kucuk, O, Saatcioglu, F, Taskèn, KA and Karlsen, SJ (2011) Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial. Nutr Cancer 63(6), 889898.CrossRefGoogle ScholarPubMed
Lengel, D, Huh, JW, Barson, JR and Raghupathi, R (2020) Progesterone treatment following traumatic brain injury in the 11-day-old rat attenuates cognitive deficits and neuronal hyperexcitability in adolescence. Exp Neurol 330, 113329.CrossRefGoogle ScholarPubMed
Marini, H, Minutoli, L, Polito, F, Bitto, A, Altavilla, D, Atteritano, M, Gaudio, A, Mazzaferro, S, Frisina, A, Frisina, N, Lubrano, C, Bonaiuto, M, D'Anna, R, Cannata, ML, Corrado, F, Adamo, EB, Wilson, S and Squadrito, F (2007) Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med 146(12), 839847.CrossRefGoogle Scholar
Miao, Z-Y, Xia, X, Che, L and Song, Y-T (2018) Genistein attenuates brain damage induced by transient cerebral ischemia through up-regulation of Nrf2 expression in ovariectomized rats. Neurol Res 40, 689695.Google ScholarPubMed
O’Brien, WT, Pham, L, Symons, GF, Monif, M, Shultz, SR and McDonald, SJ (2020) The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target. J Neuroinflamm 17(1), 112.CrossRefGoogle ScholarPubMed
Oppong‐Gyebi, A, Metzger, D, Doan, T, Han, J, Vann, PH, Yockey, RA, Sumien, N and Schreihofer, DA (2022) Long-term hypogonadism diminishes the neuroprotective effects of dietary genistein in young adult ovariectomized rats after transient focal ischemia. J Neurosci Res 100(2), 598619.CrossRefGoogle ScholarPubMed
Rabinowitz, AR and Watanabe, TK (2020) Pharmacotherapy for treatment of cognitive and neuropsychiatric symptoms after mTBI. J Head Trauma Rehabil 35(1), 7683.CrossRefGoogle ScholarPubMed
Risbrough, VB, Vaughn, MN and Friend, SF (2021) Role of inflammation in traumatic brain injury–associated risk for neuropsychiatric disorders: state of the evidence and where do we go from here. Biol Psychiatry 91(5), 438448.CrossRefGoogle Scholar
Schreihofer, DA and Oppong-Gyebi, A (2019) Genistein: mechanisms of action for a pleiotropic neuroprotective agent in stroke. Nutr Neurosci 22(6), 375391.CrossRefGoogle ScholarPubMed
Shahim, P and Zetterberg, H (2021) Neurochemical markers of traumatic brain injury: relevance to acute diagnostics, disease monitoring, and neuropsychiatric outcome prediction. Biol Psychiatry 91(5), 405412.CrossRefGoogle ScholarPubMed
Soltani, Z, Khaksari, M, Jafari, E, Iranpour, M and Shahrokhi, N (2015) Is genistein neuroprotective in traumatic brain injury? Physiol Behav 152, 2631.CrossRefGoogle ScholarPubMed
Thomas, DC, Oros‐Peusquens, A‐Maria, Schöneck, M, Willuweit, A, Abbas, Z, Zimmermann, M, Felder, Jörg, Celik, A and Shah, NJ (2023) In vivo measurement of rat brain water content at 9. 4 T MR using super-resolution reconstruction: validation with ex vivo experiments. J Magn Reson Imaging. doi: 10.1002/jmri.29061 Google Scholar
Traeger, J, Hoffman, B, Misencik, J, Hoffer, A and Makii, J (2020) Pharmacologic treatment of neurobehavioral sequelae following traumatic brain injury. Crit Care Nursing Quart 43(2), 172190.CrossRefGoogle ScholarPubMed
Vedantam, A, Brennan, J, Levin, HS, McCarthy, JJ, Dash, PK, Redell, JB, Yamal, J-M and Robertson, CS (2021) Early versus late profiles of inflammatory cytokines after mild traumatic brain injury and their association with neuropsychological outcomes. J Neurotrauma 38(1), 5362.CrossRefGoogle ScholarPubMed
Wang, S, Zhang, Z, Wang, J, Ma, L, Zhao, J, Wang, J, Fang, Z, Hou, W and Guo, H (2022) Neuronal GPER participates in genistein-mediated neuroprotection in ischemic stroke by inhibiting NLRP3 inflammasome activation in ovariectomized female mice. Mol Neurobiol 59(8), 50245040.CrossRefGoogle ScholarPubMed
Wang, S, Wang, J, Wei, H, Gu, T, Wang, J, Wu, Z and Yang, Q (2020) Genistein attenuates acute cerebral ischemic damage by inhibiting the NLRP3 inflammasome in reproductively senescent mice. Front Aging Neurosci 12, 153.CrossRefGoogle ScholarPubMed
Won, E and Kim, Y-K (2020) Neuroinflammation-associated alterations of the brain as potential neural biomarkers in anxiety disorders. Int J Mol Sci 21(18), 6546.CrossRefGoogle ScholarPubMed
Yuan, J, Wang, D, Liu, Y, Chen, X, Zhang, H, Shen, F, Liu, X and Fu, J (2018) Hydrogen-rich water attenuates oxidative stress in rats with traumatic brain injury via Nrf2 pathway. J Surg Res 228, 238246.CrossRefGoogle ScholarPubMed
Zhao, Z, Fu, J, Li, S and Li, Z (2019) Neuroprotective effects of genistein in a SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis. J Neuroimm Pharmacol 14(4), 688696.CrossRefGoogle Scholar
Supplementary material: File

Li et al. supplementary material

Li et al. supplementary material
Download Li et al. supplementary material(File)
File 258.6 KB